Tanzania Medicines and Medical Devices Authority: Control of Blood and Blood Products Regulations 2026 Gazette

• The Tanzania Medicines and Medical Devices Authority has approved and gazetted the Tanzania Medicines and Medical Devices (Control of Blood and Blood Products) Regulations, 2026, published on June 19, 2026.
• The regulations aim to ensure the safety and quality of blood products in the country and will likely impact importation and distribution of these products.
• Lawyers should be aware of the potential implications of these regulations on their clients' businesses and take steps to ensure compliance.

The new regulations are part of ongoing efforts to strengthen the regulation of blood and blood products in Tanzania.

The Tanzania Medicines and Medical Devices Authority has approved and gazetted the Tanzania Medicines and Medical Devices (Control of Blood and Blood Products) Regulations, 2026. The regulations aim to ensure the safety and quality of blood products in the country. According to Government Notice No. 149, the regulations were published on June 19, 2026. This development is significant for lawyers who advise clients on compliance with regulatory requirements in Tanzania.

The new regulations are part of ongoing efforts to strengthen the regulation of blood and blood products in Tanzania. The country has faced challenges related to the safety and quality of these products, which can have serious consequences for public health. The regulations will likely impact importation and distribution of blood products in the country, making it essential for lawyers to stay informed about compliance requirements. The regulations are also expected to provide a framework for the control of blood and blood products, ensuring that they meet international standards.

The approval and gazetting of the new regulations have significant implications for stakeholders in the healthcare industry, including lawyers who advise clients on compliance with regulatory requirements. The regulations will require importers and distributors of blood products to ensure that these products meet specific standards, which may involve additional costs and administrative burdens. Lawyers should be aware of the potential impact of these regulations on their clients' businesses and take steps to ensure compliance. This development highlights the importance of ongoing monitoring of regulatory changes in Tanzania and staying up-to-date with the latest requirements.

Lawyers should watch for compliance with the new Tanzania Medicines and Medical Devices (Control of Blood and Blood Products) Regulations, 2026, which may impact importation and distribution of blood products in the country.

Source: Original reporting via GN. NO. 149